Cytokinetics (CYTK) Change in Receivables (2016 - 2024)
Historic Change in Receivables for Cytokinetics (CYTK) over the last 9 years, with Q4 2024 value amounting to $16.4 million.
- Cytokinetics' Change in Receivables rose 144917.76% to $16.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $15.4 million, marking a year-over-year increase of 125272.89%. This contributed to the annual value of $15.4 million for FY2024, which is 125272.89% up from last year.
- Latest data reveals that Cytokinetics reported Change in Receivables of $16.4 million as of Q4 2024, which was up 144917.76% from $244000.0 recorded in Q3 2024.
- Cytokinetics' Change in Receivables' 5-year high stood at $51.2 million during Q4 2021, with a 5-year trough of -$50.8 million in Q1 2022.
- Moreover, its 5-year median value for Change in Receivables was -$449500.0 (2020), whereas its average is $324350.0.
- As far as peak fluctuations go, Cytokinetics' Change in Receivables surged by 948990.83% in 2021, and later tumbled by 5410319.15% in 2022.
- Cytokinetics' Change in Receivables (Quarter) stood at -$545000.0 in 2020, then soared by 9489.91% to $51.2 million in 2021, then tumbled by 104.2% to -$2.1 million in 2022, then surged by 43.36% to -$1.2 million in 2023, then surged by 1449.18% to $16.4 million in 2024.
- Its last three reported values are $16.4 million in Q4 2024, $244000.0 for Q3 2024, and -$834000.0 during Q2 2024.